Skip Navigation


Human Molecular Genetics Advance Access originally published online on October 9, 2007
Human Molecular Genetics 2008 17(2):201-214; doi:10.1093/hmg/ddm297
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/2/201    most recent
ddm297v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dimmer, K. S.
Right arrow Articles by Scorrano, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimmer, K. S.
Right arrow Articles by Scorrano, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETM1, deleted in Wolf–Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability

Kai Stefan Dimmer1, Francesca Navoni1, Alberto Casarin2, Eva Trevisson2, Sabine Endele3, Andreas Winterpacht3, Leonardo Salviati2 and Luca Scorrano1,*

1 Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine, 35129 Padova, Italy 2 Section of Human Genetics, Department of Paediatrics, University of Padova, 35121 Padova, Italy 3 Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-University, 91054 Erlangen, Germany

* To whom correspondence should be addressed at: Istituto Veneto di Medicina Molecolare, Via Orus 2, 35129 Padova, Italy. Tel: +39 0497923221; Fax: +39 0497923271; Email: lscorrano{at}dti.telethon.it

Received August 22, 2007; Accepted October 7, 2007

Wolf–Hirschhorn syndrome (WHS) is a complex congenital syndrome caused by a monoallelic deletion of the short arm of chromosome 4. Seizures in WHS have been associated with deletion of LETM1 gene. LETM1 encodes for the human homologue of yeast Mdm38p, a mitochondria-shaping protein of unclear function. Here we show that human LETM1 is located in the inner membrane, exposed to the matrix and oligomerized in higher molecular weight complexes of unknown composition. Down-regulation of LETM1 did not disrupt these complexes, but led to DRP1-independent fragmentation of the mitochondrial network. Fragmentation was not associated with changes in the levels of respiratory chain complexes, or with obvious or latent mitochondrial dysfunction, but was recovered by nigericin, which catalyzes the electroneutral exchange of K+ against H+. Down-regulation of LETM1 caused ‘necrosis-like’ death, without activation of caspases and not inhibited by overexpression of Bcl-2. Primary fibroblasts from a WHS patient displayed reduced LETM1 mRNA and protein, but mitochondrial morphology was surprisingly unaffected, raising the question of whether and how WHS patients counteract the consequences of monoallelic deletion of LETM1. LETM1 highlights the relationship between mitochondrial ion homeostasis, integrity of the mitochondrial network and cell viability.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.